Literature DB >> 10713480

Efficacies of tea components on doxorubicin induced antitumor activity and reversal of multidrug resistance.

Y Sadzuka1, T Sugiyama, T Sonobe.   

Abstract

Considering of novel biochemical modulation by some foods and beverages, we have performed screening for green tea components that have enhancing effects on doxorubicin (DOX) induced antitumor activity. Components, such as caffeine, theanine, (-)-epigallocatechin gallate (EGCG) and flavonoids have inhibitory effects on the DOX efflux from Ehrlich ascites carcinoma cells. Thus, it is suggested that EGCG and flavonoids may enhance DOX induced antitumor activity and increase the DOX concentrations in tumors through the inhibition of DOX efflux. It is expected that these components in green tea exhibit low toxicity and that there are few side effects of drinking green tea in combination with an antitumor agent. We think that the intake of a favorite beverage favors a positive mental attitude of a patient and increases the efficacy of the chemotherapeutic index, and that this efficacy is useful for improving the quality of life on cancer chemotherapy. In DOX resistant P388 leukemia cell bearing mice theanine increased the DOX induced efficacy through an increase in the DOX concentrations in the tumors. Theanine attacked the same transport process for DOX in both types of cells, elevated the DOX concentration and increased the DOX induced antitumor activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713480     DOI: 10.1016/s0378-4274(99)00290-8

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  8 in total

1.  Synergistic Effects of the Green Tea Extract Epigallocatechin-3-gallate and Taxane in Eradication of Malignant Human Prostate Tumors.

Authors:  Mark E Stearns; Min Wang
Journal:  Transl Oncol       Date:  2011-06-01       Impact factor: 4.243

Review 2.  Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy.

Authors:  Brahma N Singh; Bimal K Malhotra
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

3.  Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency mice.

Authors:  Mark E Stearns; Michael D Amatangelo; Devika Varma; Chris Sell; Shaun M Goodyear
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

4.  Exploring the chemical sensitivity of a carbon nanotube/green tea composite.

Authors:  Yanan Chen; Yang Doo Lee; Harindra Vedala; Brett L Allen; Alexander Star
Journal:  ACS Nano       Date:  2010-11-02       Impact factor: 15.881

5.  (-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma.

Authors:  Ting Luo; Jiao Wang; Yancun Yin; Hui Hua; Jing Jing; Xiangming Sun; Minjing Li; You Zhang; Yangfu Jiang
Journal:  Breast Cancer Res       Date:  2010-01-15       Impact factor: 6.466

6.  The effect of intra-peritoneal administration of Papaver bracteatum Lindl. extract on development of NMRI mice oocytes treated with Doxorubicin.

Authors:  Zahra Jafarian; Hussein Eimani; Mahnaz Azarnia; Abdol-Hossein Shahverdi; Poopak Eftekhari-Yazdi; Mohammad Kamalinejad
Journal:  Reprod Med Biol       Date:  2012-10-07

7.  Generating inhibitors of P-glycoprotein: where to, now?

Authors:  Emily Crowley; Christopher A McDevitt; Richard Callaghan
Journal:  Methods Mol Biol       Date:  2010

8.  The effect of grape seed and green tea extracts on the pharmacokinetics of imatinib and its main metabolite, N-desmethyl imatinib, in rats.

Authors:  Ruba S Darweesh; Tamam El-Elimat; Aref Zayed; Tareq N Khamis; Wahby M Babaresh; Tawfiq Arafat; Ahmed H Al Sharie
Journal:  BMC Pharmacol Toxicol       Date:  2020-11-16       Impact factor: 2.483

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.